Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Growth and development

How safe is growth hormone therapy for children?

Nature Reviews Endocrinology volume 6, pages 251–253 (2010)Cite this article

Subjects

A study of nearly 55,000 children finds that growth hormone therapy is generally very safe, but orthopedic problems can occur, and survivors of childhood cancer are at an increased risk of a new neoplasm. Do current treatment strategies for some targeted patient groups need reevaluation?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bell, J. et al. Long-term safety of recombinant human growth hormone in children. J. Clin. Endocrinol. Metab. 95, 167–177 (2010).

    Article  CAS  Google Scholar 

  2. [No authors listed] Leukaemia in patients treated with growth hormone. Lancet 1, 1159–1160 (1988).

  3. Nishi, Y. et al. Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. J. Clin. Endocrinol. Metab. 84, 1961–1965 (1999).

    Article  CAS  Google Scholar 

  4. Cohen, P., Clemmons, D. R. & Rosenfeld, R. G. Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm. IGF Res. 10, 297–305 (2000).

    Article  CAS  Google Scholar 

  5. Rowlands, M. A. et al. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int. J. Cancer 124, 2416–2429 (2009).

    Article  CAS  Google Scholar 

  6. Hankinson, S. E. et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351, 1393–1396 (1998).

    Article  CAS  Google Scholar 

  7. Ergun-Longmire, B. et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J. Clin. Endocrinol. Metab. 91, 3494–3498 (2006).

    Article  CAS  Google Scholar 

  8. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J. Clin. Endocrinol. Metab. 85, 3990–3993 (2000).

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Health Sciences Center, University of Oklahoma, 2500 North Philips Avenue, Suite 4500, Oklahoma City, 73104, OK, USA

    Steven D. Chernausek

Authors
  1. Steven D. Chernausek
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares associations with the following companies: Tercica (consultant), Pfizer (speakers bureau).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chernausek, S. How safe is growth hormone therapy for children?. Nat Rev Endocrinol 6, 251–253 (2010). https://doi.org/10.1038/nrendo.2010.43

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2010.43

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research